Multiple roles of ghrelin in breast cancer. Issue 3 (September 2022)

• Record Type: Journal Article
• Authors: Chen, Yiding; Han, Xuke; Wang, Lan; Wen, Qing; Li, Liufu; Sun, Lisha; Chen, Qiu
• Is Part Of: International journal of biological markers. Volume 37:Issue 3(2022)
• Page Start: 241
• Page End: 248
• Publication Date: 2022-09
• Subjects: Ghrelin -- breast cancer -- growth hormone secretagogue receptor -- GHRL -- ghrelin splicing variants; Cell receptors -- Periodicals; Histochemistry -- Periodicals; Tumor markers -- Periodicals; Tumor antigens -- Periodicals; 616.99407582
• DOI: 10.1177/03936155221110247
• Languages: English
• ISSNs: 0393-6155

Abstract

Breast cancer is one of the most threatening malignant tumors in women worldwide; hence, investigators are continually performing novel research in this field. However, an accurate prediction of its prognosis and postoperative recovery remains difficult. The severity of breast cancer is patient-specific and affected by several health factors; thus, unknown mechanisms may affect its progression. This article analyzes existing literature on breast cancer, ranging from the discovery of ghrelin to its present use, and aims to provide a reference for future research into breast cancer mechanisms and treatment-plan improvement. Various parts of ghrelin have been associated with breast cancer by direct or indirect evidence. The ghrelin system may encompass the direction of expanding breast cancer treatment methods and prognostic indicators. Therefore, we compiled almost all studies on the relationship between the ghrelin system and breast cancer, including unacylated ghrelin, its GHRL gene, ghrelin O-acyltransferase, the receptor growth hormone secretagogue receptor, and several splice variants of ghrelin to lay the foundation for future research.